Exact Sciences Corporation
Exact Sciences Corporation（EXAS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · EXAS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
9
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Exact Sciences Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
EXAS 季度内部人买卖趋势
EXAS 内幕交易卖出 · EXAS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · EXAS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
EXAS 高管卖出股份 · EXAS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 23, 2026 | Baranick Brian EVP, GM, Precision Oncology | Award | 33,321 | — | Form 4 |
| Mar 23, 2026 | Baranick Brian EVP, GM, Precision Oncology | Other | 795 | — | Form 4 |
| Mar 23, 2026 | Herriott James SVP, General Counsel & Sec | Other | 1,762 | $18 | Form 4 |
| Mar 23, 2026 | Bloomer Aaron EVP, Chief Financial Officer | Award | 89,911 | — | Form 4 |
| Mar 23, 2026 | Bloomer Aaron EVP, Chief Financial Officer | Other | 417 | — | Form 4 |
| Mar 23, 2026 | Condella Sarah EVP, Human Resources | Award | 60,389 | — | Form 4 |
| Mar 23, 2026 | Condella Sarah EVP, Human Resources | Other | 6,368 | — | Form 4 |
| Mar 23, 2026 | Conroy Kevin T President and CEO · Director | Award | 119,312 | — | Form 4 |
| Mar 23, 2026 | Conroy Kevin T President and CEO · Director | Other | 117,427 | — | Form 4 |
| Mar 23, 2026 | ORVILLE JACOB A EVP, GM, Screening | Award | 53,323 | — | Form 4 |
| Mar 23, 2026 | ORVILLE JACOB A EVP, GM, Screening | Other | 1,774 | — | Form 4 |
| Mar 23, 2026 | COWARD D SCOTT Director | Other | 52,164 | $522 | Form 4 |
| Mar 23, 2026 | COWARD D SCOTT Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | COWARD D SCOTT Director | Other | 4,694 | $47 | Form 4 |
| Mar 23, 2026 | Petrovic Shacey Director | Other | 16,406 | $164 | Form 4 |
| Mar 23, 2026 | Petrovic Shacey Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | Petrovic Shacey Director | Other | 7,095 | $71 | Form 4 |
| Mar 23, 2026 | Zanotti Katherine S Director | Other | 55,361 | $554 | Form 4 |
| Mar 23, 2026 | Zanotti Katherine S Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | Popovits Kimberly J Director | Other | 6,725 | $67 | Form 4 |
| Mar 23, 2026 | Popovits Kimberly J Director | Other | 9,656 | — | Form 4 |
| Mar 23, 2026 | Doyle James Edward Director | Other | 52,564 | $526 | Form 4 |
| Mar 23, 2026 | Doyle James Edward Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | Clancy Paul J Director | Other | 20,640 | $206 | Form 4 |
| Mar 23, 2026 | Clancy Paul J Director | Other | 5,398 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 EXAS 内幕交易
EXAS 内幕交易
Exact Sciences Corporation（EXAS）内幕交易数据来源于公司内部人（包括ORVILLE JACOB A (EVP, GM, Screening), Baranick Brian (EVP, GM, Precision Oncology), Conroy Kevin T (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。EXAS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Exact Sciences Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
EXAS 内幕交易 · 5个问题Exact Sciences Corporation（EXAS）的内部人包括高管和董事，如ORVILLE JACOB A (EVP, GM, Screening), Baranick Brian (EVP, GM, Precision Oncology), Conroy Kevin T (President and CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026